Bilberry Vaccinium myrtillus L.
Also called: whortleberry, huckleberry, dyeberry, Myrtilli fructus
Bilberry is a deciduous shrub whose dark berries resemble blueberries. Berries and leaves have been used traditionally; supplements are typically fruit extracts, promoted mainly for eye and circulatory conditions.
- Category
- Botanical
- Part used
- Fruit (fresh-fruit extracts, dried fruit); leaves also used traditionally
- Strongest evidence
- C Limited
- Native range
- Native to Greenland, temperate Eurasia, and western Canada to the northwestern and west-central US (POWO: "Greenland, Temp. Eurasia, W. Canada to NW. & WC. U.S.A.")
- Reviewed
- 2026-10-29
Class 2 Moderately studied in people. A 2004 systematic review found 12 placebo-controlled trials of oral bilberry anthocyanoside extract for night vision; 5 of them were RCTs, and the 4 most recent RCTs were negative. [3]
Fact-checked 2026-10-29 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CBrain, mood and sleep1 topic
CHeart and blood vessels1 topic
CStomach and gut1 topic
CSeveral areas, whole body or blood1 topic
XEyes1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Night vision in healthy people | X | A systematic review of 12 placebo-controlled trials found the 4 most recent RCTs negative; negative results came from more rigorous trials. Improvement of normal night vision is not supported by rigorous studies. [3] |
| Eye fatigue from screen work | C | RCT in office workers (88 enrolled, 80 completed): 480 mg/day extract for 8 weeks lessened the screen-induced drop in flicker fusion and some fatigue symptoms versus placebo; near-point accommodation did not change. [4] |
| Any health condition (overall) | C | NCCIH: bilberry has not been clearly shown to help any health condition; many studies lacked rigorous methods or enough participants. [1] |
| Heavy legs from minor venous circulation problems (EU traditional use) | C | The EU monograph accepts a standardized fresh-fruit extract for leg heaviness and capillary fragility exclusively on the basis of long-standing use. [2] |
| Mild diarrhea (EU traditional use, dried fruit) | C | The EU monograph accepts dried bilberry fruit tea for mild diarrhea and mouth rinses for minor oral inflammation exclusively on the basis of long-standing use. [5] |
Main constituents: Anthocyanins and anthocyanosides, tannins and flavonoids [1]; The EU-assessed fresh-fruit dry extract contains 36% anthocyanosides, corresponding to 25% anthocyanidins [2]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- NCCIH notes that bilberry fruit extracts have been used in research at doses of up to 160 mg/day for up to 6 months; some trials used more (see below). [1]
- Studied in a trial: 480 mg/day extract for 8 weeks. [4]
- Stated in the EU traditional-use monograph (2015): fresh-fruit dry extract 80-180 mg per dose, up to 160-540 mg/day, for 4 weeks. [2]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Score EABCDEA: well known causeE: unlikely cause
LiverTox (updated 2019-02-20): likelihood score E, unlikely cause of clinically apparent liver injury …
Details and sources - Pregnancy and breastfeedingLittle is known about whether it is safe to use bilberry in amounts greater than those in foods during pregnancy or breastfeeding.
3 statements in the profile.
Details and sources - Interactions with medicines1 listed
Warfarin and other anticoagulants
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications2 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographs2 statements
EU HMPC traditional use (29 September 2015), fresh-fruit dry extract (36% anthocyanosides), adults: 80-180 mg per dose, up to 160-540 mg/day, …
Details and sources
- Bilberry fruit is considered safe in food amounts; extracts appeared well tolerated at up to 160 mg/day for up to 6 months. Bilberry leaves may be unsafe in high doses or with long-term use. [1]
- LiverTox: not linked to liver injury; side effects are few and mild (nausea, abdominal discomfort). Bilberry may affect platelet aggregation and predispose to bleeding with anticoagulants such as warfarin. [6]
- Little is known about safety of more than food amounts in pregnancy or breastfeeding. [1]
Interactions
| With | What happens |
|---|---|
| Warfarin and other anticoagulants | Bilberry has minimal effect on drug metabolism but may affect platelet aggregation and predispose to excessive bleeding in patients on anticoagulants. [6] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- In one analysis, 45% of bilberry dietary supplements were of unacceptable quality, including bilberry-free products, products nearly free of anthocyanins or tannins, and products falsified with anthocyanins from other sources. [7]
- One extract labeled 25% anthocyanins was adulterated with the synthetic dye amaranth, detectable by HPLC but not by a single-wavelength spectrophotometric assay. [8]
- Pharmacopeial HPLC identification methods alone may not distinguish genuine bilberry extracts from adulterated material; new anthocyanin peaks and altered ratios give clues. [9]
Regulatory status
- US: FDA states that under DSHEA it does not have the authority to approve dietary supplements before they are marketed; firms are responsible for safety and labeling, and an NDI notification is required for certain new dietary ingredients. [10]
- EU: two HMPC herbal monographs (2015): dried fruit (mild diarrhea; oral mucosa) and a fresh-fruit extract (leg heaviness, capillary fragility), both traditional use. [5]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 2 entries naming bilberry (earliest NDI 1212 submitted 2021-07-13; most recent NDI 1219 submitted 2021-08-23). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. Both describe a fermented bilberry fruit extract. NDI 894 names bog bilberry (Vaccinium uliginosum), a different species. [P2]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- LiverTox (updated 2019-02-20): likelihood score E, unlikely cause of clinically apparent liver injury; not linked to serum enzyme elevations or acute liver injury. [P5]
Interactions with medicines
- Warfarin and other anticoagulants: May affect platelet aggregation and predispose to excessive bleeding; minimal effect on drug metabolism. [P5]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- Gaspar et al. 2021: 45% of tested bilberry supplements were of unacceptable quality (bilberry-free, nearly anthocyanin/tannin-free, or falsified with anthocyanins from other sources); the HPLC fingerprinting protocols were designed to detect adulteration with other Vaccinium species or elderberries. [P6]
- Penman et al. 2006: an extract labeled 25% anthocyanins contained the synthetic azo dye amaranth. [P7]
- Govindaraghavan 2014: pharmacopeial HPLC identification is not sufficient to detect adulteration of commercial bilberry extracts. [P8]
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of each component that is a dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under (a)(1)(ii). [P9]
- HPLC anthocyanin fingerprint against a bilberry reference (not single-wavelength spectrophotometry alone) — An extract adulterated with the dye amaranth matched its 25% anthocyanin claim by single-wavelength spectrophotometry; HPLC revealed the adulterant. [P7]
- Anthocyanin peak pattern and ratios — New peaks and changed compositional ratios indicate adulteration missed by pharmacopeial identification. [P8]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- EU HMPC traditional use (29 September 2015), fresh-fruit dry extract (36% anthocyanosides), adults: 80-180 mg per dose, up to 160-540 mg/day, recommended duration 4 weeks. [P10]
- EU HMPC traditional use (29 September 2015), dried fruit, age 12+: 15-60 g/day as a decoction in divided doses of 5-15 g (mild diarrhea). [P11]
Pregnancy and breastfeeding
- Little is known about whether it is safe to use bilberry in amounts greater than those in foods during pregnancy or breastfeeding. [P1]
- EU monograph, dried fruit: can be used during pregnancy and lactation; no concern about malformation after consumption of dried bilberry fruit. [P11]
- EU monograph, fresh-fruit extract: safety in pregnancy and lactation not established; use not recommended. [P10]
Sources for this profile
- NCCIH. Bilberry (Herbs at a Glance; last updated November 2024), 2024-11. nccih.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (1,060 agents, Volumes 1-142; checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports series list (607 reports; checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- NIH LiverTox (NIDDK). Bilberry (last update February 20, 2019; text read from the NCBI LitArch LiverTox archive NBK547852), 2019-02-20. ncbi.nlm.nih.gov
- Gaspar DP, et al. Quality assessment of bilberry fruits (Vaccinium myrtillus) and bilberry-containing dietary supplements. J Agric Food Chem 2021;69(7):2213-2225 (PMID 33587635), 2021-02-24. pubmed.ncbi.nlm.nih.gov
- Penman KG, et al. Bilberry adulteration using the food dye amaranth. J Agric Food Chem 2006;54(19):7378-82 (PMID 16968108), 2006-09-20. pubmed.ncbi.nlm.nih.gov
- Govindaraghavan S. Pharmacopeial HPLC identification methods are not sufficient to detect adulterations in commercial bilberry (Vaccinium myrtillus) extracts. Fitoterapia 2014;99:124-38 (PMID 25250894), 2014-12. pubmed.ncbi.nlm.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- EMA HMPC. European Union herbal monograph on Vaccinium myrtillus L., fructus recens (EMA/HMPC/375808/2014, final, 29 September 2015), 2015-09-29. ema.europa.eu
- EMA HMPC. European Union herbal monograph on Vaccinium myrtillus L., fructus siccus (EMA/HMPC/678995/2013, final, 29 September 2015), 2015-09-29. ema.europa.eu
Sources
- NCCIH. Bilberry (Herbs at a Glance; last updated November 2024), 2024-11. nccih.nih.gov
- EMA HMPC. European Union herbal monograph on Vaccinium myrtillus L., fructus recens (EMA/HMPC/375808/2014, final, 29 September 2015), 2015-09-29. ema.europa.eu
- Canter PH, Ernst E. Anthocyanosides of Vaccinium myrtillus (bilberry) for night vision: a systematic review of placebo-controlled trials. Surv Ophthalmol 2004;49(1):38-50 (PMID 14711439), 2004-01. pubmed.ncbi.nlm.nih.gov
- Ozawa Y, et al. Bilberry extract supplementation for preventing eye fatigue in video display terminal workers. J Nutr Health Aging 2015;19(5):548-54 (PMID 25923485), 2015-05. pubmed.ncbi.nlm.nih.gov
- EMA HMPC. European Union herbal monograph on Vaccinium myrtillus L., fructus siccus (EMA/HMPC/678995/2013, final, 29 September 2015), 2015-09-29. ema.europa.eu
- NIH LiverTox (NIDDK). Bilberry (last update February 20, 2019; text read from the NCBI LitArch LiverTox archive NBK547852), 2019-02-20. ncbi.nlm.nih.gov
- Gaspar DP, et al. Quality assessment of bilberry fruits (Vaccinium myrtillus) and bilberry-containing dietary supplements. J Agric Food Chem 2021;69(7):2213-2225 (PMID 33587635), 2021-02-24. pubmed.ncbi.nlm.nih.gov
- Penman KG, et al. Bilberry adulteration using the food dye amaranth. J Agric Food Chem 2006;54(19):7378-82 (PMID 16968108), 2006-09-20. pubmed.ncbi.nlm.nih.gov
- Govindaraghavan S. Pharmacopeial HPLC identification methods are not sufficient to detect adulterations in commercial bilberry (Vaccinium myrtillus) extracts. Fitoterapia 2014;99:124-38 (PMID 25250894), 2014-12. pubmed.ncbi.nlm.nih.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew. Vaccinium myrtillus L.: accepted name and native range as recorded in WCVP, the taxonomic index of POWO (WCVP Darwin Core archive, GBIF dataset f382f0ce-323a-4091-bb9f-add557f3a9a2, published 2026-06-04; read 2026-10-29), 2026-06-04. powo.science.kew.org
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.